Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function

2024 | journal article. A publication with affiliation to the University of Göttingen.

Jump to:Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function​
Gersch, S.; Lange, T.; Beuthner, B. E.; Elkenani, M.; Paul, N.; Schnelle, M. & Zeisberg, E. et al.​ (2024) 
Clinical Research in Cardiology,.​ DOI: https://doi.org/10.1007/s00392-023-02372-4 

Documents & Media

License

GRO License GRO License

Details

Authors
Gersch, Svante; Lange, Torben; Beuthner, Bo Eric; Elkenani, Manar; Paul, Niels; Schnelle, Moritz; Zeisberg, Elisabeth; Puls, Miriam; Hasenfuß, Gerd; Schuster, Andreas; Toischer, Karl
Abstract
Abstract Background Patients with severe aortic stenosis (AS) and reduced left ventricular ejection fraction (LVEF) can be distinguished into high- (HG) and low-gradient (LG) subgroups. However, less is known about their characteristics and underlying (pathophysiological) hemodynamic mechanisms. Methods 98 AS patients with reduced LVEF were included. Subgroup characteristics were analyzed by a multimodal approach using clinical and histological data, next-generation sequencing (NGS) and applying echocardiography as well as cardiovascular magnetic resonance (CMR) imaging. Biopsy samples were analyzed with respect to fibrosis and mRNA expression profiles. Results 40 patients were classified as HG-AS and 58 patients as LG-AS. Severity of AS was comparable between the subgroups. Comparison of both subgroups revealed no differences in LVEF ( p  = 0.1), LV mass ( p  = 0.6) or end-diastolic LV diameter ( p  = 0.12). Neither histological (HG: 23.2% vs. LG: 25.6%, p  = 0.73) and circulating biomarker-based assessment (HG: 2.6 ± 2.2% vs. LG: 3.2 ± 3.1%; p  = 0.46) of myocardial fibrosis nor global gene expression patterns differed between subgroups. Mitral regurgitation (MR), atrial fibrillation (AF) and impaired right ventricular function (MR: HG: 8% vs. LG: 24%; p  < 0.001; AF: HG: 30% vs. LG: 51.7%; p  = 0.03; RVSVi: HG 36.7 vs. LG 31.1 ml/m2, p  = 0.045; TAPSE: HG 20.2 vs. LG 17.3 mm, p  = 0.002) were more frequent in LG-AS patients compared to HG-AS. These pathologies could explain the higher mortality of LG vs. HG-AS patients. Conclusion In patients with low-flow severe aortic stenosis, low transaortic gradient and cardiac output are not primarily due to LV dysfunction or global changes in gene expression, but may be attributed to other additional cardiac pathologies like mitral regurgitation, atrial fibrillation or right ventricular dysfunction. These factors should also be considered during planning of aortic valve replacement. Graphical Abstract Comparison of patients with high-gradient (HG) and low-gradient (LG) aortic stenosis (AS) and reduced ejection fraction. Comprehensive analyses including clinical data, gene expression analyses, cardiovascular magnetic resonance (CMR) imaging as well as echocardiography were performed. AF: Atrial fibrillation, MR: mitral regurgitation, RVEF: right ventricular ejection fraction, ECV%: extracellular volume.
Issue Date
2024
Journal
Clinical Research in Cardiology 
Project
SFB 1002: Modulatorische Einheiten bei Herzinsuffizienz 
SFB 1002 | D04: Bedeutung der Methylierung von RNA (m6A) und des Histons H3 (H3K4) in der Herzinsuffizienz 
Working Group
RG E. Zeisberg (Kardiales Stroma) 
RG Hasenfuß (Transition zur Herzinsuffizienz) 
RG Toischer (Kardiales Remodeling) 
External URL
https://sfb1002.med.uni-goettingen.de/production/literature/publications/513
ISSN
1861-0684
eISSN
1861-0692
Language
English
Sponsor
Deutsche Forschungsgemeinschaft http://dx.doi.org/10.13039/501100001659
Herzzentrum Göttingen

Reference

Citations


Social Media